Two Sigma Advisers’s Medtronic MDT Stock Holding History

Two Sigma Advisers’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-14,000	Closed	-$867K	–	2630
2014 Q3	$867K	Buy	+14,000	New	+$890K	0.01%	1217
2014 Q2	–	Sell	-53,000	Closed	-$3.26M	–	2593
2014 Q1	$3.26M	Buy	53,000 +2,000	+4%	+$116K	0.03%	574
2013 Q4	$2.93M	Buy	51,000 +13,000	+34%	+$737K	0.03%	571
2013 Q3	$2.02M	Buy	38,000 +30,000	+375%	+$1.61M	0.02%	635
2013 Q2	$412K	Buy	+8,000	New	+$395K	0.01%	1474

Other funds holding MDT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Two Sigma Advisers's MDT Position: Q1 2026 in Review

Two Sigma Advisers sold out of Medtronic (MDT) in Q1 2026, closing a stake of 51,419 shares — an estimated $4.94M sold.

Two Sigma Advisers first reported a position in MDT in Q2 2013 and held it in 45 quarters. The position peaked at $432M in Q4 2021. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

Two Sigma Advisers reported no remaining Medtronic position as of Q1 2026 after selling out during the quarter.
Two Sigma Advisers sold 51,419 Medtronic shares in Q1 2026, an estimated $4.94M.
Two Sigma Advisers first reported a position in Medtronic in Q2 2013 and held it in 45 quarters.
Two Sigma Advisers's Medtronic position peaked at $432M in Q4 2021.
2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.